Company intelligence / Profile preview

Friedman Bioventure

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Friedman Bioventure is a venture capital firm focused on early-stage investments within the life sciences and biotechnology sectors. The firm typically targets innovative companies developing novel therapeutics, medical devices, and healthcare technologies. By providing both capital and strategic guidance, Friedman Bioventure aims to accelerate the development of breakthrough medical solutions from discovery through clinical validation. The firm's portfolio often includes companies working on high-impact areas such as oncology, rare diseases, and regenerative medicine.

Industry: Investors

Beyond the preview

Go deeper on Friedman Bioventure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Friedman Bioventure.

Explore the full profile